Detailed results from the phase 3 TEMPO trials show tavapadon offers a mechanistically distinct approach for managing motor ...

A phase 1/2 trial of a novel viral vector gene therapy in adults with type 1 diabetes is scheduled to begin this year.

An older man presents with acute coronary syndrome and a large atrial myxoma, complicating diagnosis and guiding decisions on revascularization and surgery.

Children with neurodisability are less likely to achieve expected levels of educational attainment in primary school than ...

An overnight fasting regimen beginning at least 3 hours prior to sleep shows potential benefits in blood pressure, heart rate dipping, and glucose regulation.

Patients with migraine who live in highly deprived areas have poorer mental health, with a higher risk among women and older ...

A PLOS Biology analysis finds papers led by women spend 7%-15% longer in peer review, a delay that can undermine promotion, funding, and career advancement for clinician-researchers.

The FDA approved Eli Lilly’s once-daily orforglipron GLP-1 pill (brand name Foundayo) for weight management in adults.  The ...

DENVER — Adding the weight-loss drug tirzepatide to the biologic ixekizumab significantly improved joint and skin outcomes in ...

In a small phase II study of patients with KRAS G12C-mutated NSCLC, poor performance status, not advanced age, was associated ...

Patients with chronic lymphocytic leukemia show higher risks for skin cancer, as well as skin cancer-specific metastasis and ...

Continuity of care in general practice shows a dose-dependent link to higher rates and earlier detection of hypertension in adults without existing heart conditions.